Novartis Given Reprieve In Elidel FCA Suit
A Pennsylvania federal judge on Friday dismissed a former Novartis Pharmaceuticals Corp. employee's False Claims Act suit accusing the company of off-label marketing and kickbacks related to eczema treatment Elidel, but...To view the full article, register now.
Already a subscriber? Click here to view full article